U-Blot® Research Grade Anti-RSV F/Fusion glycoprotein F0 (Cl184)Cat. No. WA2356$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-RSV F/Fusion glycoprotein F0 (Cl184)Cat. No. WA2356
U-Blot® Research Grade Anti-RSV F/Fusion glycoprotein F0 (ADI-19425)Cat. No. WA2355
U-Blot® Research Grade Anti-RSV F/Fusion glycoprotein F0 (ADI-14359)Cat. No. WA2354
U-Blot® Research Grade Anti-RSV F/Fusion glycoprotein F0 (32.4K)Cat. No. WA2353
U-Blot® Research Grade Anti-RSV F/Fusion glycoprotein F0 (01.4B)Cat. No. WA2352
U-Blot® Research Grade Anti-RGMA/RGM Antibody (H116A3)Cat. No. WA2351
U-Blot® Research Grade Anti-REGN5381 Antibody (REGN9037)Cat. No. WA2350
U-Blot® Research Grade Anti-REGN5381 Antibody (REGN9035)Cat. No. WA2349
U-Blot® Research Grade Anti-REBOV/SEBOV/TAFV/ZEBOV GP/Envelope glycoprotein Antibody (ADI-15878)Cat. No. WA2348
U-Blot® Research Grade Anti-PD-L1 & VEGF Bispecific Antibody (Pm8002)Cat. No. WA2347
U-Blot® Research Grade Anti-PD-L1 & TGF-Beta Bispecific Antibody (Tqb2858)Cat. No. WA2346
U-Blot® Research Grade Anti-pan-Ebolavirus GP/Envelope glycoprotein Antibody (ADI-15742)Cat. No. WA2345